Ascendis Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.About ASND
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs.
CEOJan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees—
Employees—
HeadquartersHellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded2006
Founded2006
Employees—
Employees—
ASND Key Statistics
Market cap14.20B
Market cap14.20B
Price-Earnings ratio-55.04
Price-Earnings ratio-55.04
Dividend yield—
Dividend yield—
Average volume673.58K
Average volume673.58K
High today$231.50
High today$231.50
Low today$226.06
Low today$226.06
Open price$226.13
Open price$226.13
Volume317.14K
Volume317.14K
52 Week high$248.60
52 Week high$248.60
52 Week low$124.06
52 Week low$124.06
ASND News
TipRanks 10h
Ascendis Pharma Reports Two-Year Data Showing Sustained Benefits of YUVIWEL in Children With AchondroplasiaAscendis Pharma ( (ASND) ) has provided an update. On March 16, 2026, Ascendis Pharma reported new two-year data from its pivotal ApproaCH trial in children wi...
TipRanks 17h
Ascendis Pharma assumed with a Buy at JefferiesJefferies assumed coverage of Ascendis Pharma (ASND) with a Buy rating and $290 price target The companyhas three approved products powered by its TransCon plat...
Analyst ratings
94%
of 18 ratingsBuy
94.4%
Hold
0%
Sell
5.6%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.